+49 7531 88 4679 Supporting Information Review SI 1: PRISMA checklist SI 2: Search strategy SI 3: List of excluded studies and reasons (k = 60) SI 4: CONSORT 2010 checklist with definitions SI 5: Cochrane risk of bias assessment across studies SI 6: Cochrane risk of bias assessment for each study SI 7: Behaviour Change Techniques (BCTs) for each study SI 8: Detailed description of included studies and analysed outcomes Meta-analysis SI 9: Funnel plot SI 10: Meta-regression and moderation effect results SI 11: Effect sizes (Cohen's d) for all analysis levels and outcomes SI 12: Effect sizes (Hedges' g) for all analysis levels and outcomes ABSTRACT Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. yes Hits: -k = 1,263 Supporting Information 3 List of excluded studies and reasons (k = 60) k = 19: No app or automated feedback Allman-Farinelli M, Partridge SR, McGeechan K, et al. A mobile health lifestyle program for prevention of weight gain in young adults (TXT2BFiT): Nine-month outcomes of a randomized controlled trial. JMIR mHealth and uHealth 2016; 4(2): e78. doi: 10.2196/mhealth.5768. Bentley CL, Otesile O, Bacigalupo R, et al. Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes.
INTRODUCTION

Rationale
3 Describe the rationale for the review in the context of what is already known. yes Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
yes
METHODS
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
The review was conducted in accordance to a predefined but not published protocol Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
yes Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
yes Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
yes Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
yes Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
yes Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
yes Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
yes Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). yes Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I 2 ) for each meta-analysis.
yes Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
yes Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
yes
RESULTS
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
yes Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. Du H, Venkatakrishnan A, Youngblood GM, Ram A, Pirolli P. A group-based mobile application to increase adherence in exercise and nutrition programs: A factorial design feasibility study. JMIR mHealth and uHealth 2016; 4(1): e4. doi: 10.2196/mhealth.4900.
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CONSORT 2010 checklist 50 with definitions All items were coded in duplicate by two independent reviewers with 0 = item not fulfilled, 0.5 = item only partially fulfilled, 1 = item fulfilled, NA = not applicable to the study.
# Item Definition
Title and Abstract 1a Identification as a randomized trial in the title 1b
Structured summary of trial design, methods, results, and conclusions Introduction 2a
Background & objectives
Scientific background and explanation of rationale 2b
Specific objectives or hypotheses Methods 3a
Trial design Description of trial design (such as parallel, factorial) including allocation ratio 3b
Important changes to methods after trial commencement (such as eligibility criteria), with reasons 4a
Participants Eligibility criteria for participants 4b
Settings and locations where the data were collected 5
Interventions
The interventions for each group with sufficient details to allow replication, including how and when they were actually administered 6a
Outcomes Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed 6b
Any changes to trial outcomes after the trial commenced, with reasons 7a
Sample size How sample size was determined 7b
When applicable, explanation of any interim analyses and stopping guidelines 8a
Random sequence generation Method used to generate the random allocation sequence 8b
Type of randomization; details of any restriction (such as blocking and block size) 9
Allocation concealment Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), describing any steps taken to conceal the sequence until interventions were assigned 10 Implementation Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions 11a Blinding If done, who was blinded after assignment to interventions (for example, participants, care providers, those assessing outcomes) and how 11b
If relevant, description of the similarity of interventions 12a
Statistical methods Statistical methods used to compare groups for primary and secondary outcomes 12b
Methods for additional analyses, such as subgroup analyses and adjusted analyses Results 13a
Participant flow
For each group, the numbers of participants who were randomly assigned, received intended treatment, and were analyzed for the primary outcome 13b
For each group, losses and exclusions after randomization, together with reasons 14a
Recruitment Dates defining the periods of recruitment and follow-up 14b
Why the trial ended or was stopped 15
Baseline data A 
Supporting Information 5
Cochrane risk of bias 53, 55 assessment across studies
Supporting Information 6
Cochrane risk of bias 53, 55 assessment for each study (H = high risk, U = unclear risk, L = low risk, NA = not applicable).
Note. Criterion for assessment of "incomplete outcome data": high = >25%, low = <25% or intention-to-treat analysis, unclear = no data provided. 
Supporting Information 8
Detailed description of included studies and analysed outcomes
Legend. 1 * = groups were pooled and combined; x = groups were excluded from analysis; + = groups were analysed separately, 2 $ app available for download. For outcomes in bold separate analyses are reported. Outcomes in Italic are pooled in the analyses of nutrition behaviours and nutrition-related health outcomes. Note. Includes intervention studies specifying absolute mean difference in BMI points (kg/m 2 ) for the intervention group. Out of 17 studies reporting BMI changes (see Supporting  Information Note. Includes intervention studies specifying absolute mean difference in body weight in kg (or lbs) for the intervention group. Out of the 31 studies reporting body weight changes (see Supporting Information 13.4), one was using a different metric (Brindal et al., 2013) , and one was excluded due to outlier values (Block et al., 2015) and thus, they were not included.
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